SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Naim Alkhouri, Anna Alisi, Vera Okwu, Ammar Matloob, Federica Ferrari, Annalisa Crudele, Rita De Vito, Rocio Lopez, Ariel E. Feldstein, Valerio Nobili, Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis, Digestive Diseases and Sciences, 2015, 60, 8, 2353

    CrossRef

  2. 2
    Kohei Oda, Hirofumi Uto, Seiichi Mawatari, Akio Ido, Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies, Clinical Journal of Gastroenterology, 2015, 8, 1, 1

    CrossRef

  3. 3
    B. Lorcerie, S. Audia, M. Samson, A. Millière, N. Falvo, V. Leguy-Seguin, S. Berthier, B. Bonnotte, Démarche diagnostique devant une hyperferritinémie, La Revue de Médecine Interne, 2015, 36, 8, 522

    CrossRef

  4. 4
    John C. Wood, Estimating tissue iron burden: current status and future prospects, British Journal of Haematology, 2015, 170, 1
  5. 5
    Koji Uchino, Ryosuke Tateishi, Naoto Fujiwara, Tatsuya Minami, Masaya Sato, Kenichiro Enooku, Hayato Nakagawa, Yoshinari Asaoka, Yuji Kondo, Haruhiko Yoshida, Kyoji Moriya, Shuichiro Shiina, Masao Omata, Kazuhiko Koike, Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients, Hepatology Research, 2015, 45, 8
  6. 6
    G. Forn-Cuni, M. Varela, C. M. Fernandez-Rodriguez, A. Figueras, B. Novoa, Liver immune responses to inflammatory stimuli in a diet-induced obesity model of zebrafish, Journal of Endocrinology, 2015, 224, 2, 159

    CrossRef

  7. 7
    Elena Buzzetti, Rosa Lombardi, Laura De Luca, Emmanuel A. Tsochatzis, Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease, International Journal of Endocrinology, 2015, 2015, 1

    CrossRef

  8. 8
    Ahilan Arulanandan, Rohit Loomba, Noninvasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?, Current Hepatology Reports, 2015, 14, 2, 109

    CrossRef

  9. 9
    Philipp Solbach, Sandra Westhaus, Maximilian Deest, Eva Herrmann, Thomas Berg, Michael P. Manns, Sandra Ciesek, Christoph Sarrazin, Thomas von Hahn, Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C Infection, CMGH Cellular and Molecular Gastroenterology and Hepatology, 2015, 1, 3, 285

    CrossRef

  10. 10
    Pathik Parikh, Jatin Patel, Meghraj Ingle, Prabha Sawant, Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India, Indian Journal of Gastroenterology, 2015, 34, 3, 200

    CrossRef

  11. 11
    Leon A. Adams, Darrell H. Crawford, Katherine Stuart, Michael J. House, Timothy G. St. Pierre, Malcolm Webb, Helena L.I. Ching, Jenny Kava, Michael Bynevelt, Gerry C. MacQuillan, George Garas, Oyekoya T. Ayonrinde, Trevor A. Mori, Kevin D. Croft, Xianwa Niu, Gary P. Jeffrey, John K. Olynyk, The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial, Hepatology, 2015, 61, 5
  12. 12
    Lisa M. Glass, Rolland C. Dickson, Joseph C. Anderson, Arief A. Suriawinata, Juan Putra, Brian S. Berk, Arifa Toor, Total Body Weight Loss of ≥10 % Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis, Digestive Diseases and Sciences, 2015, 60, 4, 1024

    CrossRef

  13. 13
    Iuliana Susnea, Ralf Weiskirchen, Trace metal imaging in diagnostic of hepatic metal disease, Mass Spectrometry Reviews, 2015, 34, 5
  14. 14
    Dechuan Kong, Haiyan Liu, Shan Wei, Yan Wang, Anqun Hu, Wenhui Han, Naiqing Zhao, Yihan Lu, Yingjie Zheng, A meta-analysis of the association between gestational diabetes mellitus and chronic hepatitis B infection during pregnancy, BMC Research Notes, 2014, 7, 1, 139

    CrossRef

  15. 15
    Manuela G. Neuman, Samuel W. French, Barbara A. French, Helmut K. Seitz, Lawrence B. Cohen, Sebastian Mueller, Natalia A. Osna, Kusum K. Kharbanda, Devanshi Seth, Abraham Bautista, Kyle J. Thompson, Iain H. McKillop, Irina A. Kirpich, Craig J. McClain, Ramon Bataller, Radu M. Nanau, Mihai Voiculescu, Mihai Opris, Hong Shen, Brittany Tillman, Jun Li, Hui Liu, Paul G. Thomes, Murali Ganesan, Steve Malnick, Alcoholic and non-alcoholic steatohepatitis, Experimental and Molecular Pathology, 2014, 97, 3, 492

    CrossRef

  16. 16
    Daniel M. Provencher, An update on nonalcoholic fatty liver disease, Journal of the American Academy of Physician Assistants, 2014, 27, 7, 18

    CrossRef

  17. 17
    Weijuan Huang, Lin Li, Xiaopeng Tian, Jinjin Yan, Xinzheng Yang, Xinlong Wang, Guozhen Liao, Genquan Qiu, Astragalus and Paeoniae�Radix�Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/smad pathway, Molecular Medicine Reports, 2014,

    CrossRef

  18. You have free access to this content18
    Masato Yoneda, Emmanuel Thomas, Yoshio Sumida, Kento Imajo, Yuichiro Eguchi, Hideyuki Hyogo, Hideki Fujii, Masafumi Ono, Takumi Kawaguchi, Eugene R. Schiff, Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution, Hepatology Research, 2014, 44, 14
  19. 19
    Dong Wook Jeong, Hye Won Lee, Young Hye Cho, Dong Won Yi, Sang Yeoup Lee, Seok Man Son, Yang Ho Kang, Comparison of Serum Ferritin and Vitamin D in Association with the Severity of Nonalcoholic Fatty Liver Disease in Korean Adults, Endocrinology and Metabolism, 2014, 29, 4, 479

    CrossRef

  20. 20
    José Manuel Fernández-Real, Melania Manco, Effects of iron overload on chronic metabolic diseases, The Lancet Diabetes & Endocrinology, 2014, 2, 6, 513

    CrossRef

  21. 21
    Elizabeth J. McKinnon, Enrico Rossi, John P. Beilby, Debbie Trinder, John K. Olynyk, Factors That Affect Serum Levels of Ferritin in Australian Adults and Implications for Follow-up, Clinical Gastroenterology and Hepatology, 2014, 12, 1, 101

    CrossRef

  22. 22
    Vincent Wai-Sun Wong, Grace Lai-Hung Wong, David Ka-Wai Yeung, Jill M Abrigo, Alice Pik-Shan Kong, Ruth Suk-Mei Chan, Angel Mei-Ling Chim, Jiayun Shen, Chung-Shun Ho, Jean Woo, Winnie Chiu-Wing Chu, Henry Lik-Yuen Chan, Fatty Pancreas, Insulin Resistance, and β-Cell Function: A Population Study Using Fat-Water Magnetic Resonance Imaging, The American Journal of Gastroenterology, 2014, 109, 4, 589

    CrossRef

  23. 23
    Svitlana Shpyleva, Marta Pogribna, Christy Cozart, Matthew S. Bryant, Levan Muskhelishvili, Volodymyr P. Tryndyak, Sharon A. Ross, Frederick A. Beland, Igor P. Pogribny, Interstrain differences in the progression of nonalcoholic steatohepatitis to fibrosis in mice are associated with altered hepatic iron metabolism, The Journal of Nutritional Biochemistry, 2014, 25, 12, 1235

    CrossRef

  24. 24
    Lidia Tomkiewicz-Pajak, Wojciech Plazak, Jacek Kolcz, Jacek Pajak, Grzegorz Kopec, Natalia Dluzniewska, Maria Olszowska, Angelina Moryl-Bujakowska, Piotr Podolec, Iron deficiency and hematological changes in adult patients after Fontan operation, Journal of Cardiology, 2014, 64, 5, 384

    CrossRef

  25. 25
    Asma Siddique, James E. Nelson, Bradley Aouizerat, Matthew M. Yeh, Kris V. Kowdley, Iron Deficiency in Patients With Nonalcoholic Fatty Liver Disease Is Associated With Obesity, Female Gender, and Low Serum Hepcidin, Clinical Gastroenterology and Hepatology, 2014, 12, 7, 1170

    CrossRef

  26. 26
    J. K. Dyson, Q. M. Anstee, S. McPherson, Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging, Frontline Gastroenterology, 2014, 5, 3, 211

    CrossRef

  27. 27
    Shane A. Wells, Quantification of Hepatic Fat and Iron with Magnetic Resonance Imaging, Magnetic Resonance Imaging Clinics of North America, 2014, 22, 3, 397

    CrossRef

  28. 28
    J K Dyson, S McPherson, Q M Anstee, Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification, Postgraduate Medical Journal, 2014, 90, 1063, 254

    CrossRef

  29. 29
    Richele L. Corrado, Dawn M. Torres, Stephen A. Harrison, Review of Treatment Options for Nonalcoholic Fatty Liver Disease, Medical Clinics of North America, 2014, 98, 1, 55

    CrossRef

  30. 30
    Prachi S. Patil, K. M. Mohandas, Shobna J. Bhatia, Shaesta A. Mehta, Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: A case–control study, Indian Journal of Gastroenterology, 2014, 33, 1, 12

    CrossRef

  31. 31
    Antonio Facciorusso, Valentina Del Prete, Matteo Antonino, Viviana Neve, Nicola Crucinio, Alfredo Di Leo, Brian I Carr, Michele Barone, Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation, Journal of Gastroenterology and Hepatology, 2014, 29, 11
  32. 32
    Douglas B. Kell, Etheresia Pretorius, Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells, Metallomics, 2014, 6, 4, 748

    CrossRef

  33. 33
    Kristina M. Utzschneider, Anna Largajolli, Alessandra Bertoldo, Santica Marcovina, James E. Nelson, Matthew M. Yeh, Kris V. Kowdley, Steven E. Kahn, Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women, Journal of Diabetes and its Complications, 2014, 28, 2, 177

    CrossRef

  34. 34
    Paul Angulo, Jacob George, Christopher P. Day, Ester Vanni, Lee Russell, Anna C. De la Cruz, Hammad Liaquat, Lavinia Mezzabotta, Eun Lee, Elisabetta Bugianesi, Serum Ferritin Levels Lack Diagnostic Accuracy for Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology and Hepatology, 2014, 12, 7, 1163

    CrossRef

  35. 35
    Stuart McPherson, Elsbeth Henderson, Alastair D. Burt, Christopher P. Day, Quentin M. Anstee, Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease, Journal of Hepatology, 2014, 60, 5, 1055

    CrossRef

  36. 36
    Ming-Yu Yang, Yuan-Cheng Chiang, Yu-Ting Huang, Chien-Chang Chen, Feng-Sheng Wang, Ching-Jen Wang, Yur-Ren Kuo, Serum Proteomic Analysis of Extracorporeal Shock Wave Therapy–Enhanced Diabetic Wound Healing in a Streptozotocin-Induced Diabetes Model, Plastic and Reconstructive Surgery, 2014, 133, 1, 59

    CrossRef

  37. 37
    Ji Hoon Na, So Won Park, Yunkoo Kang, Hong Koh, Seung Kim, The Clinical Significance of Serum Ferritin in Pediatric Non-Alcoholic Fatty Liver Disease, Pediatric Gastroenterology, Hepatology & Nutrition, 2014, 17, 4, 248

    CrossRef

  38. 38
    Moon Young Kim, The Diagnosis of Nonalcoholic Fatty Liver Disease, Korean Journal of Medicine, 2014, 86, 4, 405

    CrossRef

  39. 39
    Erika Wichro, Tanja Macheiner, Jasmin Schmid, Barbara Kavsek, Karine Sargsyan, The Wide and Complex Field of NAFLD Biomarker Research: Trends, ISRN Hepatology, 2014, 2014, 1

    CrossRef

  40. You have free access to this content40
    R. Garg, Z. Goodman, Z. Younossi, Commentary: phlebotomy in non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2013, 37, 11
  41. 41
    Philippe Sogni, Catherine Buffet, Démarche clinique devant une hyperferritinémie, La Presse Médicale, 2013, 42, 4, 405

    CrossRef

  42. 42
    Bregje van de Wier, Jiska M. Balk, Guido R.M.M. Haenen, Dimosthenis Giamouridis, Jaap A. Bakker, Bertine C. Bast, Gertjan J.M. den Hartog, Ger H. Koek, Aalt Bast, Elevated citrate levels in non-alcoholic fatty liver disease: The potential of citrate to promote radical production, FEBS Letters, 2013, 587, 15, 2461

    CrossRef

  43. 43
    Hwa Mok Kim, Bum Soo Kim, Yong Kyun Cho, Byung Ik Kim, Chong Il Sohn, Woo Kyu Jeon, Hong Joo Kim, Dong Il Park, Jung Ho Park, Kwan Joong Joo, Chang Joon Kim, Yong Sung Kim, Woon Je Heo, Won Seok Choi, Elevated red cell distribution width is associated with advanced fibrosis in NAFLD, Clinical and Molecular Hepatology, 2013, 19, 3, 258

    CrossRef

  44. 44
    Sechang Oh, Kiyoji Tanaka, Eiji Warabi, Junichi Shoda, Exercise Reduces Inflammation and Oxidative Stress in Obesity-Related Liver Diseases, Medicine & Science in Sports & Exercise, 2013, 45, 12, 2214

    CrossRef

  45. 45
    Naila Naz, Federico Moriconi, Shakil Ahmad, Ahmad Amanzada, Sajjad Khan, Sabine Mihm, Guiliano Ramadori, Ihtzaz Ahmed Malik, Ferritin L is the Sole Serum Ferritin Constituent and a Positive Hepatic Acute-Phase Protein, Shock, 2013, 39, 6, 520

    CrossRef

  46. 46
    Fabio Nascimbeni, Raluca Pais, Stefano Bellentani, Christopher Paul Day, Vlad Ratziu, Paola Loria, Amedeo Lonardo, From NAFLD in clinical practice to answers from guidelines, Journal of Hepatology, 2013, 59, 4, 859

    CrossRef

  47. 47
    Thomas Karlas, Johannes Wiegand, Thomas Berg, Gastrointestinal complications of obesity: Non-alcoholic fatty liver disease (NAFLD) and its sequelae, Best Practice & Research Clinical Endocrinology & Metabolism, 2013, 27, 2, 195

    CrossRef

  48. 48
    Christian Datz, Thomas K. Felder, David Niederseer, Elmar Aigner, Iron homeostasis in the Metabolic Syndrome, European Journal of Clinical Investigation, 2013, 43, 2
  49. 49
    Dominique Bouglé, Jacques Brouard, Iron in Child Obesity. Relationships with Inflammation and Metabolic Risk Factors, Nutrients, 2013, 5, 6, 2222

    CrossRef

  50. 50
    Luca Mascitelli, Mark R. Goldstein, Might some of the beneficial effects of the Mediterranean diet on non-alcoholic fatty liver disease be mediated by reduced iron stores?, Journal of Hepatology, 2013, 59, 3, 639

    CrossRef

  51. 51
    P.-H. Ducluzeau, J. Boursier, S. Bertrais, S. Dubois, A. Gauthier, V. Rohmer, F. Gagnadoux, G. Leftheriotis, P. Cales, R. Andriantsitohaina, V. Roullier, C. Aubé, MRI measurement of liver fat content predicts the metabolic syndrome, Diabetes & Metabolism, 2013, 39, 4, 314

    CrossRef

  52. 52
    J. K. Dyson, S. McPherson, Q. M. Anstee, Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification, Journal of Clinical Pathology, 2013, 66, 12, 1033

    CrossRef

  53. 53
    Simon Hazeldine, Debbie Trinder, John K. Olynyk, Non-Hfe Iron Overload: Is Phlebotomy the Answer?, Current Hepatitis Reports, 2013, 12, 1, 20

    CrossRef

  54. 54
    Steven G Pearce, Nirav C Thosani, Jen-Jung Pan, Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD, Biomarker Research, 2013, 1, 1, 7

    CrossRef

  55. 55
    Young Seok Kim, Eun Sun Jung, Wonhee Hur, Si Hyun Bae, Jong Young Choi, Myeong Jun Song, Chang Wook Kim, Se Hyun Jo, Chang Don Lee, Young Sok Lee, Sang Wook Choi, Jin Mo Yang, Jeong Won Jang, Sang Gyune Kim, Seung Won Jung, Hee Kyung Kim, Hee Bok Chae, Seung Kew Yoon, Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease, Clinical and Molecular Hepatology, 2013, 19, 2, 120

    CrossRef

  56. 56
    Maeva Guillaume, Vlad Ratziu, Pharmacological agents for nonalcoholic steatohepatitis, Hepatology International, 2013, 7, S2, 833

    CrossRef

  57. You have free access to this content57
    M. D. Beaton, S. Chakrabarti, M. Levstik, M. Speechley, P. Marotta, P. Adams, Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2013, 37, 7
  58. 58
    Marno C. Ryan, Paul Desmond, Andrew Wilson, Reply to: “Might some of the beneficial effects of the Mediterranean diet on non-alcoholic fatty liver disease be mediated by reduced iron stores?”, Journal of Hepatology, 2013, 59, 3, 640

    CrossRef

  59. 59
    Mohammad A. B. Al-Freah, Stephen Kriese, Matthew R. Foxton, Alberto Quaglia, Adrian Bomford, Nigel D. Heaton, John G. O'Grady, Kosh Agarwal, Julia A. Wendon, Michael A. Heneghan, The association of pretransplant ferritin level with waiting list and post-transplant survival. Does ferritin actually predict outcome?, Transplant International, 2013, 26, 11
  60. 60
    R. Büchsel, Zeigt Serumferritin den Schweregrad bei nicht alkoholischer Fettleber?, MMW - Fortschritte der Medizin, 2013, 155, 8, 36

    CrossRef

  61. 61
    Ferah Armutcu, Sumeyya Akyol, Fatma Ucar, Serpil Erdogan, Omer Akyol, 2013,

    CrossRef

  62. 62
    Levent Filik, Activin as a promising test in differential diagnosis of chronic liver diseases, European Journal of Clinical Investigation, 2012, 42, 10
  63. 63
    Jae-Jun Shim, Body iron, serum ferritin, and nonalcoholic fatty liver disease, The Korean Journal of Hepatology, 2012, 18, 1, 105

    CrossRef

  64. 64
    Garfield A. Grandison, Paul Angulo, Can Nash Be Diagnosed, Graded, and Staged Noninvasively?, Clinics in Liver Disease, 2012, 16, 3, 567

    CrossRef

  65. 65
    Dawn M. Torres, Christopher D. Williams, Stephen A. Harrison, Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology and Hepatology, 2012, 10, 8, 837

    CrossRef

  66. 66
    Swastik Agrawal, Radha K.. Dhiman, Hepatobiliary Quiz-3 (2012), Journal of Clinical and Experimental Hepatology, 2012, 2, 3, 297

    CrossRef

  67. 67
    Elena Corradini, Antonello Pietrangelo, Iron and steatohepatitis, Journal of Gastroenterology and Hepatology, 2012, 27,
  68. 68
    Swastik Agrawal, Ajay K Duseja, Non-alcoholic Fatty Liver Disease: East Versus West, Journal of Clinical and Experimental Hepatology, 2012, 2, 2, 122

    CrossRef

  69. 69
    Anil Arora, Praveen Sharma, Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease, Journal of Clinical and Experimental Hepatology, 2012, 2, 2, 145

    CrossRef

  70. 70
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2012, 16, 2, 397

    CrossRef

  71. 71
    Christopher Adlbrecht, Elmar Aigner, Juan M. Bellón, Izolde Bouloukaki, Alberto Bouzas-Mosquera, Alexandre J. F. Carrilho, Kuo-Chu Chang, Nipon Chattipakorn, Siriporn C. Chattipakorn, Yi-Jen Chen, Yuan-Chiang Chung, Roshan Colah, Christian Datz, Jens B. Frøkjær, Shunji Fujimori, Panagiota Georgiadou, Cintia M. Grion, Chih-Ping Hsu, Martin Hülsmann, Ming-Jui Hung, Ming-Yow Hung, Efstathios K. Iliodromitis, Irene M. Lang, Ting- I. Lee, Winfried März, Sona B. Nair, Gemma Pascual, Jesús Peteiro, Choitsu Sakamoto, Atsushi Satomura, Sophia E. Schiza, Peter Stärkel, Tatjana Stojakovic, David L. Vesely, Darren L. Walters, Yusuf Yilmaz, Research update for articles published in EJCI in 2010, European Journal of Clinical Investigation, 2012, 42, 11
  72. 72
    Terrence C. H. Tan, Darrell H. G. Crawford, Michael E. Franklin, Lesley A. Jaskowski, Graeme A. Macdonald, Julie R. Jonsson, Melanie J. Watson, Paul J. Taylor, Linda M. Fletcher, The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis, Liver International, 2012, 32, 9